Enzon Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Enzon Pharmaceuticals has a total shareholder equity of $46.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $47.0M and $406.0K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$46.56m |
| Equity | US$46.59m |
| Total liabilities | US$406.00k |
| Total assets | US$47.00m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: EZ1's short term assets ($46.9M) exceed its short term liabilities ($406.0K).
Long Term Liabilities: EZ1 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: EZ1 is debt free.
Reducing Debt: EZ1 had no debt 5 years ago.
Debt Coverage: EZ1 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: EZ1 has no debt, therefore coverage of interest payments is not a concern.